Insights

More Articles Back to Article

J&J's experimental Ebola vaccine to be used in the DRC this November

The Democratic Republic of Congo is set to begin using Johnson & Johnson's Ebola vaccine starting November in its eastern provinces as part of its preventive measures for combating the ongoing Ebola outbreak in the country, according to its health officials. An initial batch consisting of 500,000 doses is scheduled to arrive in the DRC next week. Reuters (10/13)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!